Biobanking for Medicine Market to reach nearly USD 64.14 Billion By 2027
Biobanking for Medicine Market is anticipated to reach nearly USD 64.14 Billion with CAGR of 6.2% through 2021 to 2027
Biobanking for Medicine Market Overview:
According to a new report published by Maximize Market Research titled Biobanking for Medicine Market by Intelligent Virtual Assistant, End User, Distribution Channel, Price, and Geography: Industry Analysis and Forecast (2021-2027).
Research assists decision makers in devising strategies and plans for their regions by analysing trends in the market, the industry environment, dominant characteristics of the market, and their short- and long-term ramifications.
The research analyzes the impact of COVID-19 lock-down on the income of industry leaders, followers, and disruptors. The impact varies by region and segment because lockdown was implemented differently in different locations and countries. The current short and long term market impact has been covered in the research, which will assist decision makers in preparing the framework for short and long term strategies for enterprises by region.
Request for free sample:
Biobanking for Medicine Market Dynamics:
The growing number of applications for Biobank samples, increased biobanking funding from government and commercial organisations, and increased genomic research efforts are all propelling the biobanking for medicine market forward. For example, in January 2021, the German Biobank node project received €3.5 million in funding from the Federal Ministry of Education and Research for a three-year period. Furthermore, the Victorian government allocated $5 million to the Doherty Institute's new COVID-19 Biobank in May 2021. The Medicines Discovery Catapult will unveil one of the world's largest virtual biobanks in August 2020.
The rapid expansion of the virtual network now includes 330 clinical sites and 1.5 million bio-samples, expanding the types of clinical samples available for drug development and diagnostic processes. The rise in chronic diseases such as autoimmune diseases, cancer, and blood disorders is fueling the growth of the biobanking for medicine market. In addition, the growing number of people suffering from chronic diseases propels the market forward.
To get a detailed report summary and research scope of Biobanking for Medicine market, click here:
Biobanking for Medicine Market Segmentation:
The Biobanking for Medicine Market is classified into Specimen Type, Biobank Type, Ownership, Application, and End-User.
The market is divided into Blood Products, Solid Tissue, Cell Lines, Nucleic Acid, and Others based on Specimen Type. By 2027, the Blood Products segment is expected to have the largest market share. This is due to an increase in the incidence of haematological illnesses, a need for blood products for specimen collection, and an increase in accidents.
During the forecast period 2021-2027, the Solid Tissue segment is expected to grow rapidly. This is due to an increase in the demand for regenerative medicines, an increase in the frequency of cardiovascular and neurological diseases, and an increase in the need for organ storage for transplant.
Biobanking for Medicine Market Key Players:
Tecan Group Ltd.
Thermo Fisher Scientific Inc.
Dickinson and Company
LVL Technologies GmbH & Co. KG
Panasonic Healthcare Holdings Co. Ltd
Greiner Bio One
Biorep Technologies Inc.
COVID-19 Impact Analysis on Biobanking for Medicine Market:
Consumer and demand movements, purchasing behaviour, supply chain transformations, and current market power dynamics are examined in the report. The impact of COVID-19 on the Biobanking for Medicine market, as well as insights, analyses, estimates, and predictions, are discussed in this updated report. In this report, we examine the impact of COVID-19 lockout on market leaders, followers, and disruptors. Based on the way the lockdown was implemented, the impact varies by location and region.
Biobanking for Medicine Market, Key Highlights:
The report provides analysis and projection of the Biobanking for Medicine market in terms of value.
Market drivers, constraints, and opportunities driving the growth of the Biobanking for Medicine Market are all examined in depth.
The Biobanking for Medicine Market has been segmented based on Intelligent Virtual Assistant, End User, Distribution Channel, Price, and geography (country-wise).
This report analyses the Biobanking for Medicine Market with respect to individual growth trends, future prospects, as well as the contribution of various submarket stakeholders.
Analysis and forecasts for the Biobanking for Medicine market for five key regions: North America, Europe, Asia Pacific, the Middle East and Africa (MEA), and Latin America, as well as country-level segmentation.
A profile of key industry participants and an analysis of core competencies are included, in addition to strategic perspectives, market positioning, and analyses of core competencies.
The top companies active in the Biobanking for Medicine Market are profiled in terms of their competitive advancements, investments, strategic growth, and competitive landscape.
About Maximize Market Research:
Maximize Market Research, an industry research firm with a dedicated team of specialists and data, has conducted comprehensive research on the Biobanking for Medicine market. Maximize Market Research provides B2B and B2C research on 6,500 high-growth, emerging technologies for the chemical, healthcare, pharmaceutical, electronics, Internet of Things, food and beverage, aerospace, and defence industries. Maximize Market Research analyses the competitive landscape of sectors in addition to evaluating and estimating market size.
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT Park Phase 2, Pune Bangalore Highway,
Narhe, Pune, Maharashtra 411041, India.
Phone No.: +91 20 6630 3320